… doses of glucocorticoids decreases bone mass … of glucocorticoid receptors across all skeletal
cell populations and their respective progenitors, therapeutic glucocorticoids affect skeletal …

… glucocorticoid or combination treatments. This review will outline the known mechanism of
bone loss … Osteoporosis treatment with specific consideration for patients with vasculitis will be …

… corticosteroids are able to enter bone cells. Here 11β-HSD1 can further activate and amplify
the actions of corticosteroids … bone metabolism in osteoclasts, osteocytes and osteoblasts. …

… For more than 70 years, glucocorticoids (GCs) have been a powerful and affordable
treatment option for inflammatory diseases. However, their benefits do not come without a cost, …

… itself hamper bone integrity. GC signaling is also important for fracture healing and rheumatoid
… This review summarizes the complexity of GC actions via GR in bone cells at cellular and …

… has been demonstrated to diminish rheumatic disease … corticosteroids on a group of
patients with chronic obstructive pulmonary disease concluded that this therapy may affect bone …

… Glucocorticoids are the gold standard treatment for reducing immune activation and
inflammation in a wide range of inflammatory and systemic autoimmune diseases. Glucocorticoids …

… risk have been presented that take into account glucocorticoid dosage for the Fracture Risk
… GCs are administered; bone loss is more rapid in the first months of therapy. Patients on GCs …

… % of US patients with chronic conditions warranting glucocorticoid exposure received any
… studies of glucocorticoid effects on bone cell function have been recently published (39, 43). …

… Moreover, as glucocorticoids still represent a leading treatment for systemic … rheumatological
diseases, our secondary aim is to summarize the main effects of glucocorticoids treatment …